| Financial Year |
September 30 2022 |
| Monetary Funds |
146,353,851.16 |
| Held-for-trading Financial Assets |
12,141,976.76 |
| Notes Receivable |
1,858,246.04 |
| Accounts Receivable |
91,287,060.85 |
| Advances to Suppliers |
3,017,490.46 |
| Other Receivables |
7,194,173.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
53,991,182.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,966,886.59 |
| Total Current Assets |
317,810,868.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
38,432,477.92 |
| Investment Properties |
97,315,753.52 |
| Fixed Assetes |
125,808,506.32 |
| Under-construction Projects |
11,302,271.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,654,148.23 |
| R&D expenses |
-- |
| Goodwill |
182,133,110.30 |
| Long-Term Deferred and Prepaid Expenses |
77,440,585.50 |
| Deferred Income Tax Assets |
9,378,439.97 |
| Other Non-Current Assets |
361,117,118.00 |
| Sub-Total of Non-Current Assets |
1,082,555,818.35 |
| Total Assets |
1,400,366,686.67 |
| Short-Term Loans |
50,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
26,980,337.89 |
| Accounts Received In Advance |
4,348,434.14 |
| Employee Compensation Payable |
15,054,808.69 |
| Taxes Payable |
11,887,184.98 |
| Interest Payable |
-- |
| Dividend Payable |
138,916.27 |
| Other payables |
59,364,155.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,006,894.91 |
| Other Current Liabilities |
881,113.31 |
| Sub-Total of Current Liabilities |
237,537,891.12 |
| Long-term Loans |
52,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
33,875,998.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
218,796,803.05 |
| Total Liabilities |
456,334,694.17 |
| Paid-In Capital(Or Share Stock) |
780,000,000.00 |
| Capital Surplus |
55,901,055.35 |
| Surplus Reserve |
138,768,496.04 |
| LESS:Treasury Stock |
25,006,950.00 |
| Undistributed Profits |
-57,442,315.67 |
| Minority Stockholder's Interest |
41,751,417.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
902,280,575.21 |
| Owner's Equity（Stockholder's Equity） |
944,031,992.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,400,366,686.67 |
